Skip to main content
Premium Trial:

Request an Annual Quote

FDA Releases New EUA Guidance for MDx Labs Offering SARS-CoV-2 Testing

NEW YORK – The US Food and Drug Administration on Tuesday released new guidance for Emergency Use Authorization for molecular-based laboratory developed tests (LDTs) detecting SARS-CoV-2. 

Under the guidance, molecular-based LDTs for qualitative detection of nucleic acid from SARS-CoV-2 in respiratory specimens that are authorized for use by the developing laboratory can be performed, but only in the CLIA-certified laboratory in which the test was developed.  

Tests are eligible for authorization under the EUA if the lab has submitted an EUA request for the LDT with required data, and if they are either new and not covered at the time of the EUA request or significantly different from an existing EUA-authorized test. The test must also be a reverse transcription PCR test using authorized material components and control materials.

The new guidance follows the FDA's pathway "Policy A," which allows labs to use validated SARS-CoV-2 LDTS on patient samples as soon as they are validated internally if they have notified the FDA and file an EUA application within 15 days. 

Yale New Haven Hospital's Clinical Virology Laboratory was granted an EUA for its SARS-CoV-2 RT-PCR test under the new guidance on Tuesday.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.